Well Lead Medical Co., Ltd. (603309.SS)
CNY 12.51
(0.89%)
CNY 12.51
(0.89%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 609.28 Million CNY | -0.16% |
| 2022 | 588.85 Million CNY | 24.27% |
| 2021 | 473.84 Million CNY | -4.22% |
| 2020 | 494.72 Million CNY | 12.51% |
| 2019 | 439.71 Million CNY | 67.64% |
| 2018 | 262.29 Million CNY | 21.95% |
| 2017 | 215.09 Million CNY | 11.58% |
| 2016 | 192.77 Million CNY | 5.07% |
| 2015 | 183.46 Million CNY | 2.57% |
| 2014 | 178.86 Million CNY | 11.92% |
| 2013 | 159.82 Million CNY | 16.49% |
| 2012 | 137.19 Million CNY | 22.55% |
| 2011 | 111.95 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 170.26 Million CNY | 15.19% |
| 2024 Q1 | 141.26 Million CNY | -21.74% |
| 2024 Q2 | 147.8 Million CNY | 4.64% |
| 2023 Q3 | 144 Million CNY | 5.4% |
| 2023 Q2 | 136.61 Million CNY | -16.15% |
| 2023 FY | 587.9 Million CNY | -0.16% |
| 2023 Q1 | 162.92 Million CNY | 4.93% |
| 2023 Q4 | 180.51 Million CNY | 25.36% |
| 2022 FY | 588.85 Million CNY | 24.27% |
| 2022 Q3 | 166.32 Million CNY | 16.8% |
| 2022 Q2 | 142.4 Million CNY | 14.05% |
| 2022 Q1 | 124.86 Million CNY | -14.22% |
| 2022 Q4 | 155.27 Million CNY | -6.65% |
| 2021 Q4 | 145.56 Million CNY | 15.04% |
| 2021 Q1 | 93.52 Million CNY | -13.64% |
| 2021 FY | 473.84 Million CNY | -4.22% |
| 2021 Q2 | 108.21 Million CNY | 15.7% |
| 2021 Q3 | 126.53 Million CNY | 16.93% |
| 2020 Q4 | 108.3 Million CNY | -20.48% |
| 2020 Q2 | 184.41 Million CNY | 180.22% |
| 2020 Q1 | 65.81 Million CNY | -49.45% |
| 2020 FY | 494.72 Million CNY | 12.51% |
| 2020 Q3 | 136.19 Million CNY | -26.14% |
| 2019 Q2 | 114.56 Million CNY | 42.06% |
| 2019 FY | 439.71 Million CNY | 67.64% |
| 2019 Q1 | 80.64 Million CNY | -17.87% |
| 2019 Q4 | 130.19 Million CNY | 13.9% |
| 2019 Q3 | 114.3 Million CNY | -0.23% |
| 2018 Q2 | 59.74 Million CNY | 39.33% |
| 2018 Q3 | 61.48 Million CNY | 2.91% |
| 2018 Q4 | 98.19 Million CNY | 59.71% |
| 2018 FY | 262.29 Million CNY | 21.95% |
| 2018 Q1 | 42.87 Million CNY | -26.54% |
| 2017 FY | 215.09 Million CNY | 11.58% |
| 2017 Q4 | 58.37 Million CNY | 14.26% |
| 2017 Q3 | 51.08 Million CNY | -19.48% |
| 2017 Q1 | 42.19 Million CNY | -28.42% |
| 2017 Q2 | 63.44 Million CNY | 50.36% |
| 2016 Q1 | 37.76 Million CNY | -29.49% |
| 2016 Q4 | 58.94 Million CNY | 16.08% |
| 2016 FY | 192.77 Million CNY | 5.07% |
| 2016 Q3 | 50.78 Million CNY | 12.16% |
| 2016 Q2 | 45.27 Million CNY | 19.88% |
| 2015 Q3 | 50.27 Million CNY | 13.45% |
| 2015 Q1 | 35.3 Million CNY | -26.8% |
| 2015 FY | 183.46 Million CNY | 2.57% |
| 2015 Q4 | 53.56 Million CNY | 6.54% |
| 2015 Q2 | 44.31 Million CNY | 25.54% |
| 2014 Q2 | 49.42 Million CNY | 42.1% |
| 2014 Q4 | 48.22 Million CNY | 3.87% |
| 2014 Q1 | 34.78 Million CNY | 0.0% |
| 2014 FY | 178.86 Million CNY | 11.92% |
| 2014 Q3 | 46.43 Million CNY | -6.05% |
| 2013 FY | 159.82 Million CNY | 16.49% |
| 2012 FY | 137.19 Million CNY | 22.55% |
| 2011 FY | 111.95 Million CNY | 0.0% |